Bryan Lewis
About Bryan Lewis
Bryan Lewis is the Scientific Director of CMC Team Leadership at Bristol Myers Squibb and the Founder & CEO of Riverbend CMC, LLC, with extensive experience in pharmaceutical sciences and clinical supplies operations.
Current Position at Bristol Myers Squibb
Bryan Lewis is currently the Scientific Director for the CMC Team Leadership at Bristol Myers Squibb in New Brunswick, New Jersey, United States. In this role, Bryan oversees various aspects related to Chemistry, Manufacturing, and Controls (CMC) processes. His responsibilities likely include the management of multi-million dollar CMC budgets and providing scientific advice for regulatory submissions.
Role at Riverbend CMC, LLC
Bryan Lewis is the Founder and CEO of Riverbend CMC, LLC located in the Greater New York City Area. This consulting company specializes in serving non-profit foundations and small biopharmaceutical companies. Bryan's leadership extends to providing guidance on GMP API manufacture, managing CDMO operations, and contributing to international on-site audits across several countries. He successfully identified and hired a team of 10 CMC experts within 18 months.
Former Position at Axovant Sciences
Bryan Lewis served as the Vice President of Pharmaceutical Sciences at Axovant Sciences from 2015 to 2017 in the Greater New York City Area. During his tenure, he was responsible for leading pharmaceutical scientific operations and contributing to regulatory interactions, including presentations of EOP2 and Pre-NDA meeting packages to the FDA.
Tenure at Eisai Inc.
From 2009 to 2015, Bryan Lewis worked at Eisai Inc. as the Executive Director of Clinical Supplies and Operations in Woodcliff Lake, NJ. Prior to this role, he was the Director of Process Research at Eisai Research Institute in Andover, MA, from 2006 to 2009. His responsibilities spanned clinical supplies management and process research, along with leading initiatives in long-term stability study development for small molecules and biologics.
Educational Background
Bryan Lewis holds a Ph.D. in Chemistry from Scripps Research, where he studied from 1993 to 1999. He completed his undergraduate studies in Chemistry at Drexel University, earning a B.S. degree from 1988 to 1993. His academic background laid a solid foundation for his extensive career in pharmaceuticals and CMC leadership.